Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Non-monosexual Partnerships: Information, Motivation and Self-Efficacy among Methamphetamine-Using Men Who Have Sex with Men Who Also Have Sex with Women or Transgender Persons.

Noor SW, Wilkerson JM, Schick V, Iantaffi A.

Int J Sex Health. 2016;28(3):205-215. doi: 10.1080/19317611.2016.1168903. Epub 2016 Apr 21.

2.

Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Soontornniyomkij V, Kesby JP, Morgan EE, Bischoff-Grethe A, Minassian A, Brown GG, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Neuroimmune Pharmacol. 2016 Sep;11(3):495-510. doi: 10.1007/s11481-016-9699-0. Epub 2016 Aug 2. Review.

3.

Intimate partner violence among men and women who use methamphetamine: A mixed-methods study in South Africa.

Watt MH, Guidera KE, Hobkirk AL, Skinner D, Meade CS.

Drug Alcohol Rev. 2017 Jan;36(1):97-106. doi: 10.1111/dar.12420. Epub 2016 Jun 1.

PMID:
27246967
4.

Methamphetamine Use and Violent Behavior: User Perceptions and Predictors.

Brecht ML, Herbeck D.

J Drug Issues. 2013 Oct;43(4):468-482. Epub 2013 Jun 14.

5.

Methamphetamine-induced deficits in social interaction are not observed following abstinence from single or repeated exposures.

Janetsian SS, McCane AM, Linsenbardt DN, Lapish CC.

Behav Pharmacol. 2015 Dec;26(8 Spec No):786-97. doi: 10.1097/FBP.0000000000000158.

6.

A Population Pharmacokinetic Analysis of Dextroamphetamine in the Plasma and Hair of Healthy Adults.

Roberts JK, Cook SF, Stockmann C, Rollins DE, Wilkins DG, Sherwin CM.

Clin Drug Investig. 2015 Oct;35(10):633-43. doi: 10.1007/s40261-015-0323-5.

7.

HIV Subtypes B and C gp120 and Methamphetamine Interaction: Dopaminergic System Implicates Differential Neuronal Toxicity.

Samikkannu T, Rao KV, Salam AA, Atluri VS, Kaftanovskaya EM, Agudelo M, Perez S, Yoo C, Raymond AD, Ding H, Nair MP.

Sci Rep. 2015 Jun 9;5:11130. doi: 10.1038/srep11130.

8.

Violence perpetrated by women who use methamphetamine.

Hamilton AB, Goeders NE.

J Subst Use. 2010 Oct;15(5):313-329.

9.

Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention.

Trivedi MS, Deth R.

Front Neurosci. 2015 Jan 22;8:444. doi: 10.3389/fnins.2014.00444. eCollection 2014. Review.

10.

Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.

Courtney KE, Ray LA.

Drug Alcohol Depend. 2014 Oct 1;143:11-21. doi: 10.1016/j.drugalcdep.2014.08.003. Epub 2014 Aug 17. Review.

11.

Chlorogenic and caftaric acids in liver toxicity and oxidative stress induced by methamphetamine.

Koriem KM, Soliman RE.

J Toxicol. 2014;2014:583494. doi: 10.1155/2014/583494. Epub 2014 Jul 20.

12.

Repeated Acquisition in the Morris Swim Task: Effects of MDMA, Methamphetamine and Methylphenidate.

Galizio M, Byrd BD, Robinson AM, Hawkey A, Rayburn-Reeves R, April LB.

Psychol Rec. 2014 Jun 1;64(2):143-150.

13.

The association between family flexibility, food preoccupation and body image among crystal abuser women.

Rahmatizadeh M, Khodabakhshi Koolaee A.

Int J High Risk Behav Addict. 2012 Fall;1(3):126-31. doi: 10.5812/ijhrba.7503. Epub 2012 Nov 26.

14.

Functional changes of the reward system underlie blunted response to social gaze in cocaine users.

Preller KH, Herdener M, Schilbach L, Stämpfli P, Hulka LM, Vonmoos M, Ingold N, Vogeley K, Tobler PN, Seifritz E, Quednow BB.

Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2842-7. doi: 10.1073/pnas.1317090111. Epub 2014 Jan 21.

15.

Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Wood S, Sage JR, Shuman T, Anagnostaras SG.

Pharmacol Rev. 2013 Dec 16;66(1):193-221. doi: 10.1124/pr.112.007054. Print 2014. Review.

16.

Extended-access, but not limited-access, methamphetamine self-administration induces behavioral and nucleus accumbens dopamine response changes in rats.

Le Cozannet R, Markou A, Kuczenski R.

Eur J Neurosci. 2013 Nov;38(10):3487-95. doi: 10.1111/ejn.12361. Epub 2013 Sep 23.

17.

Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in rats.

Wilmouth CE, Zheng G, Crooks PA, Dwoskin LP, Bardo MT.

Pharmacol Biochem Behav. 2013 Nov;112:29-33. doi: 10.1016/j.pbb.2013.09.006. Epub 2013 Sep 26.

18.

Cocaine users manifest impaired prosodic and cross-modal emotion processing.

Hulka LM, Preller KH, Vonmoos M, Broicher SD, Quednow BB.

Front Psychiatry. 2013 Sep 5;4:98. doi: 10.3389/fpsyt.2013.00098. eCollection 2013.

19.

Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: protective effects of selenium.

Barayuga SM, Pang X, Andres MA, Panee J, Bellinger FP.

Neurotoxicology. 2013 Jul;37:240-6. doi: 10.1016/j.neuro.2013.05.009. Epub 2013 May 27.

20.

Pharmacotherapy of amphetamine-type stimulant dependence: an update.

Brensilver M, Heinzerling KG, Shoptaw S.

Drug Alcohol Rev. 2013 Sep;32(5):449-60. doi: 10.1111/dar.12048. Epub 2013 Apr 25. Review.

Supplemental Content

Support Center